TrovaGene Inc. said that Stanley Tennant will resign as a director, effective Dec. 31.

Tennant's resignation is due to personal reasons and not a result of any disagreement with the company, its management or board, TrovaGene said in a Dec. 10 regulatory document.

San Diego-based Trovagene is a clinical-stage biopharmaceutical company focused on developing oncology therapeutics.